Multiple sclerosis (MS) is a chronic, progressive, and disabling inflammatory neurologic condition that causes more disability than any other nontraumatic neurologic condition. Early diagnosis, treatment, and monitoring of disease progression are fundamental to optimizing management of patients with MS. Here, we present an online learning module that covers key principles in all phases of management, with a focus on up-to-date and evidence-based principles of providing high-quality care.

Presenting Faculty

• Bio

  Edward J. Fox, MD, PhD

  ×

  Dr. Fox is the director of the Multiple Sclerosis Clinic of Central Texas, and is the founding partner of Central Texas Neurology Consultants in Round Rock, Texas.   After receiving a Bachelors Degree at Washington University in St. Louis, he completed the Medical Scientist Training Program for his M.D., Ph.D. and his Neurology residency at Baylor College of Medicine in Houston.  His Ph.D. in Immunology was awarded in 1987 for the thesis “Growth Requirements of Human Suppressor T Lymphocytes.”  Since starting a private Neurology practice in the Austin area in 1992, he has been involved in numerous MS research protocols and has spoken internationally on topics related to Neuroimmunology.  Dr. Fox is a Fellow of the American Academy of Neurology.  He served as President of the Texas Neurological Society in 2019-2020.  He has an appointment as Clinical Associate Professor of Neurology at the University of Texas Dell Medical School at Austin. He has been an active member of CMSC for over 20 years and is currently the Senior Member-at-Large of the Executive Committee of the CMSC Board.

  Close
  

  Edward J. Fox, MD, PhD

  Director, MS Clinic of Central Texas
  Central Texas Neurology Consultants, PA
  Clinical Associate Professor, University of Texas Dell Medical School
  Round Rock, Texas

• Bio

  Matthew K. Schindler, MD, PhD

  ×

  Matthew K. Schindler, MD, PhD, is an assistant professor in the Department of Neurology in the Division of Multiple Sclerosis and Related Disorders at the Perelman School of Medicine of the University of Pennsylvania in Philadelphia. Dr. Schindler received his MD and PhD degrees in neuroscience at Wake Forest University School of Medicine. He completed his neurology residency at the University of Pennsylvania and was a recipient of the National MS Society-American Brain Foundation Clinician Scientist Development Award. With this grant, he completed a neuroimmunology fellowship at the National Institute of Neurological Disorders and Stroke Translational Neuroradiology Section laboratory directed by Dr. Daniel Reich. During his fellowship, Dr. Schindler’s research focused on using advanced imaging techniques, including ultra-high field MRI (7T), to probe both common and rare neuroinflammatory diseases.

  Dr. Schindler received an NIH Director’s Merit Award for work related to providing neurological care and clinical research in Liberia following the Ebola epidemic. He is also a recipient of a KL2 award through the Institute of Translational Medicine and Therapeutics at the University of Pennsylvania. His current research includes studying novel imaging biomarkers that can be used to predict tissue injury, with a focus on 7-tesla MRI, differences in outcomes across the age-span in MS, and integrating advanced clinical imaging techniques to improve MS diagnosis and treatment monitoring.

  Close

  Contributing Faculty

  

  Matthew K. Schindler, MD, PhD

  Assistant Professor of Neurology, MS Division
  Perelman School of Medicine
  University of Pennsylvania
  Philadelphia, Pennsylvania